Tyra biosciences to present at upcoming investor conferences

Carlsbad, calif. , nov. 10, 2022 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that the company will be presenting and hosting one-on-one meetings at the following conferences in november: h.c.
TYRA Ratings Summary
TYRA Quant Ranking